TRACON Pharmaceuticals (TCON) Revenue & Revenue Breakdown
TRACON Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$12.04M
Latest Revenue (Q)
$100.00K
TRACON Pharmaceuticals Revenue by Period
TRACON Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $12.04M | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $346.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $3.00M | -65.73% |
| 2017-12-31 | $8.76M | 153.84% |
| 2016-12-31 | $3.45M | -56.36% |
| 2015-12-31 | $7.90M | 119.68% |
| 2014-12-31 | $3.60M | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
TRACON Pharmaceuticals generated $12.04M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 401.50% compared to the same period a year ago.
TRACON Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $100.00K | -96.72% |
| 2023-12-31 | $3.04M | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $9.00M | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $-346.00K | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $346.00K | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | -100.00% |
| 2018-03-31 | $3.00M | 100.00% |
| 2017-12-31 | - | -100.00% |
| 2017-09-30 | $7.50M | 1088.27% |
| 2017-06-30 | $631.00K | 0.80% |
| 2017-03-31 | $626.00K | 1.46% |
| 2016-12-31 | $617.00K | -24.29% |
| 2016-09-30 | $815.00K | 0.99% |
| 2016-06-30 | $807.00K | -33.31% |
| 2016-03-31 | $1.21M | -13.26% |
| 2015-12-31 | $1.40M | 18.22% |
| 2015-09-30 | $1.18M | -71.88% |
| 2015-06-30 | $4.20M | 270.76% |
| 2015-03-31 | $1.13M | 8.85% |
| 2014-12-31 | $1.04M | -8.21% |
| 2014-09-30 | $1.13M | 5.99% |
| 2014-06-30 | $1.07M | 200.28% |
| 2014-03-31 | $356.00K | 100.00% |
| 2013-12-31 | - | - |
TRACON Pharmaceuticals generated $100.00K in revenue during Q1 2024, up -96.72% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
TRACON Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KRON | Kronos Bio | $6.29M | $2.37M |
| XOMA | XOMA | $4.76M | $7.20M |
| ADXN | Addex Therapeutics | $1.61M | $235.00K |
| IKT | Inhibikase Therapeutics | $260.50K | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| ACXP | Acurx Pharmaceuticals | - | - |
| ENTX | Entera Bio | - | $42.00K |
| TPST | Tempest Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| ACHL | Achilles Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |
| MNPR | Monopar Therapeutics | - | - |
| VINC | Vincerx Pharma | - | - |
| CADL | Candel Therapeutics | - | - |
| CYCN | Cyclerion Therapeutics | - | $194.00K |